Amy Krane, Marketing QPID Health has been selected to participate in the first ever Innovation Lab at the Southern California HIMSS event. We will share our latest tools that expedite quality and registry submissions and support real-time surveillance of quality issues. It’s a great time to year to be in Los Angeles, so stop by on March 2. More on the event
MedCity News,Dec. 2, 2014 Dan Verel Digital health startup QPID Health recently announced that its EHR augmentation software was adopted by Silver Hill Hospital, a psychiatric hospital in Connecticut that hopes to glean better insights on behavioral health patterns of an often-challenging patient population. QPID, a Boston-based startup founded in 2012, said its software will help the 129-bed hospital capture and display an “at-a-glance view of clinically relevant information.” The hospital, meanwhile, said the software will help it maximize EHR data and spot patterns for improved treatment on the psychiatric side, which has been a growing focus as the health system as a whole looks to curb hospitalizations. The collaboration will also include a behavioral health portal with the use of QPID’s Cohort App, which identifies and collects information across various groups of patients. The QPID platform will mine data to track compliance and quality metrics related to what’s known as hospital based inpatient psychiatric services, a program instituted to specifically geared toward the safety of psych patients. Read the full article: MedCity News,Dec. 2, 2014
QPID Health Recognized by Distinguished Panel of Healthcare CIOs
Boston – November 25, 2014 – QPID Health announced today that is has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare. The Company’s Q-Guide product is recognized as a finalist in the category of Clinical Information Management. Finalists were selected by a distinguished panel of CIOs from renowned U.S. hospitals and healthcare systems, including Allina Health, Rush University Medical Center, Mayo Clinic and JFK Health System. A complete list of judges can be found at: https://www.fierceinnovationawards.com/healthcare/2014/judges. The Fierce Innovation Awards recognize pioneering technologies and solutions that will catapult healthcare delivery into new realms. “Our finalists represent the exciting innovation happening in the healthcare industry today,” said Wendy Johnson, FierceMarkets’ healthcare group publisher. “These companies have developed game-changing technologies and solutions that can improve safety, efficiency and patient outcomes.” All applications were evaluated based on the following criteria: quality of care and patient outcomes, care efficiency, financial impact, market validation and overall innovative “fierceness.” Finalists were selected based on calculation of the judges’ scores in each area. Mike Doyle, CEO of QPID Health, comments: “We’re proud to have been selected as a finalist in this year’s Fierce Innovation Awards in the Clinical Information Management category for our product Q-Guide, which we developed in collaboration with Partners HealthCare. Overuse of tests and procedures costs an estimated $46 billion annually here in the U.S. Q-Guide was designed to address that issue. Ensuring appropriate use is important for patient care and is imperative for healthcare providers that are accountable for improving clinical outcomes while reducing care costs. With Q-Guide, we combine best practice guidelines with the patient’s own health information, using our unique ability to pry concepts from structured and unstructured data stored in medical records. To learn more about QPID Health, visit http://dev.qpidhealth.com/About FierceMarkets FierceMarkets, a wholly owned subsidiary of Questex Media Group, is a leader in B2B emedia, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets’ wide array of publications reaches more than 1.3 million executives in more than 100 countries. Current publications include: Energy: FierceEnergy; FierceSmartGrid; Smart Grid NewsHealthcare: FierceEMR; FierceHealthcare; FierceHealthFinance; FierceHealthIT; FierceHealthPayer; FierceHealthPayerAnti-Fraud; FierceMedicalImaging; FierceMobileHealthcare; FiercePracticeManagement; Hospital Impact Telecom: FierceWireless; FierceCable; FierceDeveloper; FierceOnlineVideo; FierceTelecom; FierceWirelessTech; FierceWireless:Europe / TelecomsEMEA, Telecom Asia; Life Sciences:FierceBiotech; FierceBiotechIT; FierceBiotech Research; FierceCRO; FierceDiagnostics, FierceDrugDelivery; FierceMedicalDevices; FiercePharma; FiercePharmaMarketing; FiercePharmaManufacturing; FierceVaccines; FierceAnimalHealth Enterprise IT: FierceBigData; FierceCIO; FierceCIO:TechWatch; FierceContentManagement; FierceMobileIT; FierceEnterpriseCommunications; Finance: FierceCFO; FierceFinanceIT; Government: FierceGovernment; FierceGovernmentIT; FierceHomelandSecurity; FierceMobileGovernment; Marketing & Retail: FierceCMO; FierceMobileMarketer; FierceMobileRetail; FierceRetail; and FierceRetailIT. About QPID Health QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. QPID extracts patient information from the EHR using natural language processing and machine learning. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital and usage spread virally throughout the Partners HealthCare system including to Brigham & Women’s Hospital, Faulkner and Newton-Wellesley. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Usage has grown from 4000 to 7000 active users over the past year supporting 3 million clinical encounters. Investors include Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization, New Leaf Venture Partners, and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information. Media Contact:Ceara O’Sullivan NextStep Communications email@example.com (315) 567-2528
HealthLeaders Media, Nov. 13, 2014 Scott Mace The next generation of decision-support technology leverages natural language processing (NLP) and continues to evolve by scouring unstructured text and presenting evidence-based medicine to providers in new, accessible, and interesting ways. In two of the latest examples, clinicians themselves contribute via a growing set of predefined queries, as evidenced by Partner HealthCare’s use of QPID, a queriable patient inference dossier technology recently spun out into its own Boston-based company; as well as threaded, Facebook-like conversations behind the firewall, as epitomized by the Mayo Clinic’s recent six-month pilot test of Dabo, a technology developed by a San Francisco–based company in which Mayo has an ongoing investment. The result of both initiatives, executives say, is energized physicians who are helping themselves and each other achieve healthcare’s Triple Aim: improving the patient experience of care, improving the health of populations, and reducing the per capita cost of healthcare. The QPID technology originated when radiologists at Massachusetts General Hospital, a 999-bed teaching hospital in Boston, realized they were wasting too much time hunting through electronic medical records, looking for important information when making decisions, says Greg Pauly, chief operating officer of Massachusetts General Physicians Organization. “Once this bubbled up to management, there were a variety of other potential uses for this kind of technology,” he says. “That’s when we added to the resources to make it available to other departments, such as the ED, GI, and PATA [pre-admission testing area].” Read the full article: HealthLeaders Media, Nov. 13, 2014
QPID Health Further Strengthens Clinical and Leadership Team
Boston – November 18, 2014 – QPID Health, a leader in clinical intelligence software, today announced that Afik Gal, MD, MBA has joined the Company as VP of Product Innovation. An expert in healthcare analytics, digital health, and data mining, Dr. Gal brings over a decade of experience in healthcare product development and consulting to QPID Health. Dr. Gal’s role will be key in steering the Company’s next generation of products as QPID Health expands across provider, payer and consumer markets. Prior to joining QPID Health, Dr. Gal was with PWC Consulting in the Healthcare Innovation and Healthcare Incubation Lab in Boston, where he advised clients in healthcare, technology, pharmacy, and biotech on strategy and new business. Previously, Dr. Gal founded and led a boutique consulting firm and a healthcare analytics startup company. Dr. Gal holds an MBA from Duke University and an MD from Ben-Gurion University in Israel. “Afik brings a unique background to our leadership team,” said Mike Doyle, QPID Health Chief Executive Officer. “His medical training and clinical experience combined with his expertise in technology design, development, and implementation – as well as healthcare business models – make him an excellent fit for our organization’s next phase of growth.” “Clinicians—including physicians and nurses—are an important part of our team,” explained Doyle. “Our customers benefit from their deep knowledge of the challenges of patient care, as well as their medical subject matter expertise. We employ clinicians in our content development, account management, support and product development functions.” “I’m honored to join QPID Health as VP of product innovation,” says Dr. Gal. “As the healthcare industry becomes more and more data-driven, I see a tangible need for support from technology solutions like QPID. QPID Health has the potential to revolutionize the ways clinicians interact with clinical data at the point-of-care. I look forward to collaborating with the team in place as we work to improve upon the healthcare delivery successes we enable.” About QPID Health QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. QPID extracts patient information from the EHR using natural language processing and machine learning. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital and usage spread virally throughout the Partners HealthCare system including to Brigham & Women’s Hospital, Faulkner and Newton-Wellesley. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Usage has grown from 4000 to 7000 active users over the past year supporting 3 million clinical encounters. Investors include Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization, New Leaf Venture Partners, and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information. Media Contact:Ceara O’Sullivan NextStep Communications firstname.lastname@example.org (315) 567-2528
The Company’s Growth Necessitates Additional Space and Staff to Facilitate Product Development and Service Customers Nationwide
Boston – September 16, 2014 – QPID Health,a leader in clinical intelligence software, today announced a move to new headquarters in Boston and their first West Coast location in San Diego. The new headquarters at 175 Federal Street in Boston will house product development, engineering, operations and marketing teams. QPID Health’s new Southern California office will be located at 1000 Aviara Parkway in Carlsbad. The expansion was needed in order to meet the demands of customers nationwide. Both new locations will be operational at the end of October.
The QPID software platform enables healthcare providers to get the most from their investment in electronic health records (EHRs) by delivering relevant patient information where and when it is needed. EHRs are difficult to use and waste valuable clinician time because of the high volume of data they contain and because they are not organized the way clinicians think. QPID solves that problem.
QPID Health formally launched in late 2012. Since raising $12.3M in venture funding as part of the Company’s Series B earlier this year, the Company has invested in product development and services to further the core mission of ‘Improving Healthcare’. Moving to new space is imperative to support the Company’s growth.
“Our move to a larger Boston headquarters, opening of the San Diego facility, and our willingness to embrace remote employee arrangements underscore our commitment to hiring the best available people, no matter where they are located,” explained Mike Doyle, President & CEO of QPID Health. “I’m grateful for the passion of my team and look forward to our move, as it affords us the ability to further develop our technology and work toward improved clinical care.”
In 2013, QPID Health’s first year of commercial operation, 4,000 active users generated nearly 3 million clinical encounters with QPID’s platform at Partners HealthCare hospitals including Massachusetts General Hospital and Brigham & Women’s Hospital. Today, over 6,000 active users are benefiting from QPID solutions, both within and outside of the Partners network.
About QPID Health
QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital (MGH) and usage spread virally throughout the Partners HealthCare system hospitals and affiliates including Brigham & Women’s Hospital, Dana-Farber Cancer Institute, Faulkner, Newton-Wellesley Hospital, and North Shore Hospital as well as MGH. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Investors include Matrix Partners, Cardinal Partners, New Leaf Venture Partners, Massachusetts General Physicians Organization and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.
Whether a healthcare organization is attesting to Stage 1 or Stage 2 of meaningful use this year, the process may not be entirely intuitive for physicians and other clinicians responsible for documenting patient care. At Massachusetts General Hospital (MGH),physicians have a little bit of help from the hospital’s Queriable Patient Information Dossier (QPID), a clinical analytics engine developed at the hospital that provides actionable insights drawn from patient information stored in EHRs and data repositories, making meaningful use attestation just a little bit easier for harried clinicians.
“You can imagine that with all the components of meaningful use that our physicians are responsible for, they are begging the hospital leadership to help them get the data that they need to put into the chart and do it in a way that doesn’t require them to take their energies away from seeing the patient,” says Dr. David Ting, Associate Medical Director for Information Systems at the MGH Physicians Organization.